administered intracerebroventricularly to sheep. J Vet
Pharmacol Ther 10: 210–217.
Bergmeyer HU, Brent E (1972) Assay with pyruvate and NADH.
In: Methods in Enzymatic Analysis, vol. 2. Academic Press,
London pp. 574–577.
Blackburn RE, Samson WK, Fulton RJ, Stricker EM, Verbalis JG
(1993) Central oxytocin inhibition of salt appetite in rats:
evidence for differential sensing of plasma sodium and
osmolality. Proc Natl Acad Sci USA 90: 10380–10384.
Bojanowska E, Guzek JW, Dabrowski R (1999) Luteinizing
hormone-releasing hormone and function of the
magnocellular vasopressinergic system. Neuropeptides 33:
301–305.
Bojanowska E, Juszczak M, Guzek JW, Dabrowski R (2000)
Luteinizing hormone-releasing hormone and oxytocin
response to hyperosmotic stimulation: in vitro study. Brain
Res Bull 52: 303–307.
Bradford MM (1976) A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal Biochem 72: 248–254.
Charli JL, Vargas MA, Cisneros M, De Gortari P, Baeza MA, Jasso
P, Bourdais J, Perez L, Uribe RM, Joseph-Bravo P (1998) TRH
inactivation in the extracellular compartment: role of
pyroglutamyl peptidase II. Neurobiology (Bp) 6: 45–57.
Cheng KW, Leung PC (2000) The expression, regulation and
signal transduction pathways of the mammalian
gonadotropin-releasing hormone receptor. Can J Physiol
Pharmacol 78: 1029–1052.
Ciosek J, Guzek JW, Orlowska-Majdak M (1993) Thyrotropinreleasing hormone (TRH) modulates vasopressin and
oxytocin release from the hypothalamo-neurohypophyseal
system in dehydrated rats. J Physiol Pharmacol 44:
293–302.
Ciosek J, Stempniak BJ (1995) Thyrotropin-releasing hormone
(TRH) modifies oxytocin release from the
hypothalamo-neurohypophyseal system in salt-loaded rats.
Physiol Pharmacol 46: 169–177.
Cummins PM, O'Connor B (1996) Bovine brain pyroglutamyl
aminopeptidase (Type-1): purification and characterisation
of a neuropeptide-inactivating peptidase. Int J Biochem Cell
Biol 28: 883–893.
Cummins PM, O'Connor B (1998) Pyroglutamyl peptidase: an
overview of the three known enzymatic forms. Biochim
Biophys Acta 1429: 1–17.
De Caro G, Massi M (1985) Water intake modifications induced
by tachykinins, bombesins and opioid peptides. Peptides 3
(Suppl. 6): 181–185.
De Caro G, Polidori C, Menani JV, Johnson AK (1997) Bombesin
affects the central nervous system to produce sodium intake
inhibition in rats. Physiol Behav 63: 15–23.
De Gandarias JM, Irazusta J, Gil J, Varona A, Ortega F, Casis L
(2000) Subcellular ontogeny of brain pyroglutamyl peptidase
I. Peptides 21: 509–517.
Evered MD (1983) Neuropeptides and thirst. Prog
Neuropsychopharmacol Biol Psychiatry 7: 469–476.
Griffiths EC (1987) Clinical applications of thyrotrophinreleasing hormone. Clin Sci (Lond) 73: 449–457.
Guarini S, Tagliavini S, Bazzani C, Bertolini A (1989) Bombesin
reverses bleeding-induced hypovolemic shock in rats. Life
Sci 45: 107–116.
Hawkins MF, Baker JD, Baumeister AA (1989) Neurotensininduced polydipsia: a structure-activity study. Brain Res
487: 188–191.
